Mass General Brigham Launches Genetic Test for Eight Cardiovascular Conditions
The clinician-ordered test integrates polygenic risk scores validated in over 236,000 participants from the NIH’s All of Us Research Program.
Read MorePosted by CLP Edit Staff | Sep 10, 2025 | Sequencing Systems |
The clinician-ordered test integrates polygenic risk scores validated in over 236,000 participants from the NIH’s All of Us Research Program.
Read MorePosted by CLP Edit Staff | Sep 5, 2025 | POC Rapid Assays |
The test detects early albumin markers in urine within 10 minutes, targeting high-risk diabetes and hypertension patients.
Read MorePosted by CLP Edit Staff | Sep 2, 2025 | Analytical Software Systems |
Mount Sinai researchers develop machine learning approach that analyzes common clinical data to determine penetrance of rare genetic variants.
Read MorePosted by CLP Edit Staff | Aug 25, 2025 | Dementias & Alzheimer’s |
C2N Diagnostics has expanded the intended use of its PrecivityAD2 Alzheimer’s disease blood test to include patients 50 years and older, lowering the previous age limit from 60 years.
Read MorePosted by Editorial Staff | Jul 30, 2025 | Diagnostic Technologies |
The expansion of at-home testing is reshaping the landscape of clinical diagnostics, affecting clinical lab volumes and the role of lab professionals.
Read More